The Efavirenz (EFV) central nervous system exposure sub-study
Phase 3
Completed
- Conditions
- HIVInfection - Acquired immune deficiency syndrome (AIDS / HIV)
- Registration Number
- ACTRN12612001194853
- Lead Sponsor
- Kirby Institute, University of New South Wales
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All subjects entering into the main study protocol at participating centres will be eligible to enter this sub-study
Exclusion Criteria
Existing neurological disease which in the opinion of the
investigator would be a contra-indication to lumbar
puncture examination
CNS opportunistic infections in the past 12 weeks
Bacterial or viral meningitis in the past 12 weeks
Head injury requiring medical assessment in the past 12 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method